eMedicine Specialties > Vascular Surgery > Medical Topics

Peripheral Arterial Occlusive Disease: Differential Diagnoses & Workup

Author: Vincent Lopez Rowe, MD, Assistant Professor of Surgery, Department of Surgery, Division of Vascular Surgery, University of Southern California Medical Center
Contributor Information and Disclosures

Updated: Oct 26, 2009

Differential Diagnoses

Buerger Disease (Thromboangiitis Obliterans)
Spinal Stenosis
Chronic Venous Insufficiency
Varicose Veins
Compartment Syndrome, Lower Extremity
Degenerative Disk Disease
Osteoarthritis

Other Problems to Be Considered

Some disease processes mimic claudication symptoms and must be excluded. They include the following:

  • Osteoarthritis: This is associated with arthritic pain that is variable from day to day and may be aggravated by certain weather patterns or movements. Rest does not relieve pain.
  • Venous disease: Described as a dull, aching pain that typically occurs at the end of the day or after prolonged standing, venous disease is not exacerbated by exercise.
  • Neurospinal disease: Pain occurs in the morning and is not relieved by short resting periods. Neurospinal pain is frequently relieved by leaning forward against a solid surface or by sitting.
  • Chronic compartment syndrome: This is rare. It is usually observed in runners and other athletes with large, developed calf muscles. Muscles swell during activity, leading to increased compartment pressure and decreased venous return. Consistent with claudication pain, this pain occurs with exercise and is relieved with rest. However, the type of exercise is at a more strenuous level and the recovery period is prolonged.
  • Popliteal entrapment syndrome: This syndrome is similar to intermittent claudication but is usually observed in active young people. The syndrome is caused by various abnormal anatomical configurations of the insertion of the medial gastrocnemius muscle head, which causes compression of the popliteal artery. Upon physical examination, tibial pulses may disappear when the knee is at full extension. Pain is aggravated with walking but not with running because knee extension is not as severe with running.
  • Reflex sympathetic dystrophy or minor causalgia: This is characteristically described as a burning pain. The superficial pain is often distributed along a somatic nerve and is often related to a past trauma in the extremity.
  • Diabetic neuropathy: Pain is due to a peripheral neuritis. Differentiation from intermittent claudication can be difficult because of accompanying skin discoloration and diminished pulses. An extensive neurologic evaluation is essential.
  • Venous thrombosis: Swelling and leg pain occur with walking. Pain is relieved by extremity elevation, which distinguishes this entity from arterial insufficiency.

Workup

Laboratory Studies

A laboratory workup is only helpful for identifying accompanying silent alterations in renal function and elevated lipid profiles.

Imaging Studies

  • Angiography still remains the criterion standard arterial imaging study used in the diagnosis of PAOD (see Image 2). However, this test is usually reserved for when an intervention (either endovascular or traditional open surgery) is planned.
  • Monaco et al examined the effects of systematic (routine) coronary angiography on patients undergoing surgical treatment of peripheral arterial disease.2 Patients undergoing vascular surgery have a high-risk for cardiovascular complications and mortality. The authors found that routine coronary angiography had a positive impact compared with selectively determining if coronary angiography was needed. The routine coronary angiography improved survival (P=0.01) and no reports of death or cardiovascular events (P=0.003) occurred compared with those patients who were selectively chosen to have coronary angiography prior to vascular surgery. The authors recommend that multicenter trials confirm this finding in a larger population.
Peripheral arterial occlusive disease. This angio...

Peripheral arterial occlusive disease. This angiogram shows a superficial femoral artery occlusion on one side (with reconstitution of the suprageniculate popliteal artery) and superficial femoral artery stenosis on the other side. This is the most common area for peripheral vascular disease.

Peripheral arterial occlusive disease. This angio...

Peripheral arterial occlusive disease. This angiogram shows a superficial femoral artery occlusion on one side (with reconstitution of the suprageniculate popliteal artery) and superficial femoral artery stenosis on the other side. This is the most common area for peripheral vascular disease.

  • Magnetic resonance angiography (MRA) is useful for imaging large and small vessels. Although MRA was initially felt to provide inadequate images, this is no longer the case. With improved imaging capabilities, MRA can be used to not only diagnose but to help plan the type of indicated intervention.
  • Computerized tomographic angiography is another modality used to image arterial disease. Unfortunately, the study still requires a large amount of contrast media and requires an upgraded CT scanner to reconstruct helpful images.
  • Duplex ultrasonography is a method of evaluating the status of a patient’s vascular disease. Duplex scanning has the advantage of being noninvasive and requiring no contrast media. Unfortunately, duplex scanning is very technician dependent.

Other Tests

See Physical.

More on Peripheral Arterial Occlusive Disease

Overview: Peripheral Arterial Occlusive Disease
Differential Diagnoses & Workup: Peripheral Arterial Occlusive Disease
Treatment & Medication: Peripheral Arterial Occlusive Disease
Follow-up: Peripheral Arterial Occlusive Disease
Multimedia: Peripheral Arterial Occlusive Disease
References

References

  1. Boyd AM. The natural course of arteriosclerosis of the lower extremities. Angiology. 1960;11:10.

  2. [Best Evidence] Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB, et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol. Sep 8 2009;54(11):989-96. [Medline].

  3. O'Donnell ME, Badger SA, Sharif MA, Young IS, Lee B, Soong CV. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease. J Vasc Surg. May 2009;49(5):1226-34. [Medline].

  4. Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T, Lindholt JS. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg. Oct 2009;38(4):463-74. [Medline].

  5. Samson RH. The role of statin drugs in the management of the peripheral vascular patient. Vasc Endovascular Surg. Aug-Sep 2008;42(4):352-66. [Medline].

  6. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. Apr 2007;45(4):645-654; discussion 653-4. [Medline].

  7. Cassar K, Bachoo P, Ford I, et al. Platelet activation is increased in peripheral arterial disease. J Vasc Surg. Jul 2003;38(1):99-103. [Medline].

  8. Clifford PC, Davies PW, Hayne JA, Baird RN. Intermittent claudication: is a supervised exercise class worth while?. Br Med J. Jun 21 1980;280(6230):1503-5. [Medline].

  9. Collins TC, Petersen NJ, Suarez-Almazor M, Ashton CM. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med. Jun 23 2003;163(12):1469-74. [Medline].

  10. Couch NP. On the arterial consequences of smoking. J Vasc Surg. May 1986;3(5):807-12. [Medline].

  11. Cronenwett JL, Warner KG, Zelenock GB, et al. Intermittent claudication. Current results of nonoperative management. Arch Surg. Apr 1984;119(4):430-6. [Medline].

  12. Ekroth R, Dahllof AG, Gundevall B, et al. Physical training of patients with intermittent claudication: indications, methods, and results. Surgery. Nov 1978;84(5):640-3. [Medline].

  13. Green RM, McNamara J. The effects of pentoxifylline on patients with intermittent claudication. J Vasc Surg. Feb 1988;7(2):356-62. [Medline].

  14. Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. Br Med J. May 27 1978;1(6124):1379-81. [Medline].

  15. Jonason T, Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand. 1985;218(1):27-33. [Medline].

  16. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. Jan 1985;33(1):13-8. [Medline].

  17. Kannel WB, Skinner JJ, Schwartz MJ, Shurtleff D. Intermittent claudication. Incidence in the Framingham Study. Circulation. May 1970;41(5):875-83. [Medline].

  18. Porter JM, Cutler BS, Lee BY, et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J. Jul 1982;104(1):66-72. [Medline].

  19. Reid DD, Brett GZ, Hamilton PJ, et al. Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet. Mar 23 1974;1(7856):469-73. [Medline].

  20. Rosenbloom MS, Flanigan DP, Schuler JJ, et al. Risk factors affecting the natural history of intermittent claudication. Arch Surg. Jul 1988;123(7):867-70. [Medline].

  21. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol. May 1992;45(5):529-42. [Medline].

  22. Walsh DB, Gilbertson JJ, Zwolak RM, et al. The natural history of superficial femoral artery stenoses. J Vasc Surg. Sep 1991;14(3):299-304. [Medline].

  23. Rowe VL, Lee W, Weaver FA, Etzioni D. Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg. Apr 2009;49(4):910-7. [Medline].

Further Reading

Keywords

peripheral arterial occlusive disease, PAOD, chronic arterial insufficiency, lower extremity claudication, lower extremity ischemia, lower-extremity claudication, lower-extremity ischemia, peripheral vascular disease, cholesterol, smoking, hypertension

Contributor Information and Disclosures

Author

Vincent Lopez Rowe, MD, Assistant Professor of Surgery, Department of Surgery, Division of Vascular Surgery, University of Southern California Medical Center
Vincent Lopez Rowe, MD is a member of the following medical societies: American College of Surgeons, Association for Academic Surgery, Peripheral Vascular Surgery Society, Society for Clinical Vascular Surgery, and Society for Vascular Surgery
Disclosure: Nothing to disclose.

Medical Editor

William H Pearce, MD, Chief, Division of Vascular Surgery, Violet and Charles Baldwin Professor of Vascular Surgery, Department of Surgery, Northwestern University School of Medicine
William H Pearce, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, American Surgical Association, Association for Academic Surgery, Association of VA Surgeons, Central Surgical Association, New York Academy of Sciences, Society for Vascular Surgery, Society of Critical Care Medicine, Society of University Surgeons, and Western Surgical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Travis J Phifer, MD, Chief, Division of Vascular Surgery, Professor, Department of Surgery and Radiology, Louisiana State University Health Sciences Center in Shreveport
Travis J Phifer, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Surgeons, American Medical Association, Association for Academic Surgery, Society for Academic Emergency Medicine, Society for Vascular Surgery, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

William H Pearce, MD, Chief, Division of Vascular Surgery, Violet and Charles Baldwin Professor of Vascular Surgery, Department of Surgery, Northwestern University School of Medicine
William H Pearce, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, American Surgical Association, Association for Academic Surgery, Association of VA Surgeons, Central Surgical Association, New York Academy of Sciences, Society for Vascular Surgery, Society of Critical Care Medicine, Society of University Surgeons, and Western Surgical Association
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.